Cost-effectiveness of high-dose versus standard-dose inactivated influenza vaccine in adults aged 65 years and older: an economic evaluation of data from a randomised controlled trial
Chit, Ayman, Dr, Becker, Debbie L, MSc, DiazGranados, Carlos A, MD, Maschio, Michael, MSc, Yau, Eddy, PhD, Drummond, Michael, Prof
Published in The Lancet infectious diseases (01.12.2015)
Published in The Lancet infectious diseases (01.12.2015)
Get full text
Journal Article